Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Japan Planning To Expand Phase I Waivers
Under Certain Conditions
Oct 05 2023
•
By
Lisa Takagi
MHLW has basically required local Phase I trials since 2007, but eased requirements from 2014 • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Japan
More from Asia